Gilles Berger

Prof. Dr. Gilles Berger

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2015 in Polymer Chemistry
Verified
Journal Article
Closed access
PDF file
GBGilles Berger
Gilles Berger
JSJalal Soubhye
Jalal Soubhye
Franck MeyerFranck Meyer
Franck Meyer
The applications of halogen bonding in surface functionalization, soft, luminescent and magnetic materials, interpenetrated networks, synthetic methods, and separation and inclusion techniques are reviewed.

5 July 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
GBGilles Berger
Gilles Berger
Erik KnelsonErik Knelson
Erik Knelson
JJJorge L. Jimenez-Macias
Jorge L. Jimenez-Macias
MNMichal O. Nowicki
Michal O. Nowicki
SHSaemi Han
Saemi Han
SLSean Lawler
Sean Lawler
Immunotherapy has had a tremendous impact on cancer treatment in the past decade, with hitherto unseen responses at advanced and metastatic stages of the disease. However, the aggressive brain tumor glioblastoma (GBM) is highly immunosuppressive and remains largely refractory to current immunotherapeutic approaches. The stimulator of interferon genes (STING) DNA sensing pathway has emerged as a next-generation immunotherapy target with potent local immune stimulatory properties. Here, we investigated the status of the STING pathway in GBM and the modulation of the brain tumor microenvironment (TME) with the STING agonist ADU-S100. Our data reveal the presence of STING in human GBM specimens, where it stains strongly in the tumor vasculature. We show that human GBM explants can respond to STING agonist treatment by secretion of inflammatory cytokines. In murine GBM models, we show a profound shift in the tumor immune landscape after STING agonist treatment, with massive infiltration of the tumor-bearing hemisphere with innate immune cells including inflammatory macrophages, neutrophils, and natural killer (NK) populations. Treatment of established murine intracranial GL261 and CT-2A tumors by biodegradable ADU-S100–loaded intracranial implants demonstrated a significant increase in survival in both models and long-term survival with immune memory in GL261. Responses to treatment were abolished by NK cell depletion. This study reveals therapeutic potential and deep remodeling of the TME by STING activation in GBM and warrants further examination of STING agonists alone or in combination with other immunotherapies such as cancer vaccines, chimeric antigen receptor T cells, NK therapies, and immune checkpoint blockade.

7 April 2020 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
GBGilles Berger
Gilles Berger
PFPierre Frangville
Pierre Frangville
Franck MeyerFranck Meyer
Franck Meyer
This review highlights recent developments of halogen bonding in materials and biological sciences with a short discussion on the nature of the interaction.

1 May 2019 in Trends in Molecular Medicine
Verified
Journal Article
Closed access
GBGilles Berger
Gilles Berger
MMMickaël Marloye
Mickaël Marloye
SLSean Lawler
Sean Lawler

14 January 2016 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
ACAmit Kumar Chattopadhyay
Amit Kumar Chattopadhyay
VLVu Linh Ly
Vu Linh Ly
SJShashidhar Jakkepally
Shashidhar Jakkepally
GBGilles Berger
Gilles Berger
SHStephen Hanessian
Stephen Hanessian

22 November 2016 in Future Medicinal Chemistry
Verified
Journal Article
Closed access
MMMickaël Marloye
Mickaël Marloye
GBGilles Berger
Gilles Berger
MGMichel Gelbcke
Michel Gelbcke
François DufrasneFrançois Dufrasne
François Dufrasne
Metal complexes have been the subject of numerous investigations in oncology but, despite the plethora of newly synthesized compounds, their precise mechanisms of action remain generally unknown or, for the best, incompletely determined. The continuous development of efficient and sensitive techniques in analytical chemistry and molecular biology gives scientists new tools to gather information on how metal complexes can be effective toward cancer. This review focuses on recent findings about the anticancer mechanism of action of metal complexes and how the ligands can be used to tune their pharmacological and physicochemical properties.